We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4.69B
AUM Growth
-$822M
Cap. Flow
-$1.14B
Cap. Flow %
-24.25%
Top 10 Hldgs %
55.86%
Holding
70
New
9
Increased
11
Reduced
30
Closed
13

Top Buys

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$104M
2
AMZN icon
Amazon
AMZN
+$66.3M
3
USFD icon
US Foods
USFD
+$56.4M
4
MTOR
MERITOR, Inc.
MTOR
+$36.2M
5
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$25.6M

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$133M
2
WTW icon
Willis Towers Watson
WTW
+$111M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$110M
4
PARA
Paramount Global Class B
PARA
+$105M
5
COR icon
Cencora
COR
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 58.05%
2 Technology 9.88%
3 Industrials 8.96%
4 Materials 7.92%
5 Consumer Discretionary 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HYPR icon
51
Hyperfine
HYPR
$97.5M
$7.25M 0.15%
+1,000,000
New +$7.92M
MRTX
52
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$6.72M 0.14%
45,800
– –
OUST icon
53
Ouster
OUST
$3.07B
$6.25M 0.13%
120,198
– –
OHPAU
54
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$4.78M 0.1%
485,001
-14,999
-3% -$149K
EVLV icon
55
Evolv Technologies
EVLV
$1.07B
$3.34M 0.07%
749,461
-100,539
-12% -$564K
DMRC icon
56
Digimarc Corp
DMRC
$171M
$2.96M 0.06%
+75,000
New +$3.25M
EOLS icon
57
Evolus
EOLS
$488M
$2.56M 0.05%
+393,827
New +$2.7M
CCC
58
CCC Intelligent Solutions
CCC
$3.83B
– –
-2,405,960
Closed -$25.3M
ELV icon
59
Elevance Health
ELV
$84.9B
– –
-88,011
Closed -$32.8M
META icon
60
Meta Platforms (Facebook)
META
$1.5T
– –
-205,401
Closed -$69.7M
MOH icon
61
Molina Healthcare
MOH
$10B
– –
-330,105
Closed -$89.6M
OGN icon
62
Organon & Co
OGN
$3.56B
– –
-753,127
Closed -$24.7M
PARA
63
DELISTED
Paramount Global Class B
PARA
– –
-2,667,822
Closed -$105M
TAK icon
64
Takeda Pharmaceutical
TAK
$54.4B
– –
-8,102,119
Closed -$133M
V icon
65
Visa
V
$692B
– –
-134,630
Closed -$30M
ATIP.WS
66
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
– –
-300,000
Closed -$198K
VELOW
67
DELISTED
Velocity Acquisition Corp. Warrant
VELOW
– –
-244,060
Closed -$171K
FST
68
DELISTED
FAST Acquisition Corp.
FST
– –
-878,761
Closed -$11.2M
BOWX
69
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
– –
-757,294
Closed -$7.57M
ATIP
70
DELISTED
ATI Physical Therapy, Inc.
ATIP
– –
-4,983
Closed -$947K
1 2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Glenview Capital Management held 70 positions worth $4.69B, down 15% from $5.51B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Glenview Capital Management withdrew a net $1.14B in Q4 2021, closing 13 positions and reducing 30 holdings. Its most notable exit was Takeda Pharmaceutical, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 60% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glenview Capital Management opened a new position in Amazon worth $64.6M.

  • Glenview Capital Management's largest Q4 2021 buy was Amazon: 387,500 shares worth $64.6M.
  • Glenview Capital Management added most to Global Payments in Q4 2021, an estimated $104M increase.
  • Glenview Capital Management's biggest Q4 2021 reduction was Willis Towers Watson, cutting an estimated $111M.
  • Glenview Capital Management fully exited Takeda Pharmaceutical in Q4 2021, selling an estimated $133M.
  • Glenview Capital Management's ten largest holdings make up 56% of its $4.69B portfolio in Q4 2021.
  • Glenview Capital Management opened 9 new positions and closed 13 in Q4 2021.
  • Glenview Capital Management's portfolio value fell 15% quarter-over-quarter to $4.69B.

Based on Glenview Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.